BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu XF, Zhang H, Zhu SG, Zhou XT, Su HL, Xu Z, Li SJ. Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma. World J Gastroenterol 2006; 12(29): 4706-4709 [PMID: 16937443 DOI: 10.3748/wjg.v12.i29.4706]
URL: https://www.wjgnet.com/1007-9327/full/v12/i29/4706.htm
Number Citing Articles
1
Maria Pia Santacroce, M. C. Conversano, E. Casalino, O. Lai, C. Zizzadoro, G. Centoducati, G. Crescenzo. Aflatoxins in aquatic species: metabolism, toxicity and perspectivesReviews in Fish Biology and Fisheries 2008; 18(1): 99 doi: 10.1007/s11160-007-9064-8
2
X-F Liu, H Jiang, C-S Zhang, S-P Yu, Z-Q Wang, H-L Su. Targeted Drug Regulation on Methylation of p53—BAX Mitochondrial Apoptosis Pathway Affects the Growth of Cholangiocarcinoma CellsJournal of International Medical Research 2012; 40(1): 67 doi: 10.1177/147323001204000107
3
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma2013; : 111 doi: 10.1007/978-94-007-6473-6_10
4
Alfredo Guglielmi, Andrea Ruzzenente, Calogero Iacono. Surgical Treatment of Hilar and Intrahepatic CholangiocarcinomaUpdates in Surgery 2008; : 75 doi: 10.1007/978-88-470-0729-1_8
5
Christopher D. Briggs, Christopher P. Neal, Christopher D. Mann, William P. Steward, Margaret M. Manson, David P. Berry. Prognostic molecular markers in cholangiocarcinoma: A systematic reviewEuropean Journal of Cancer 2009; 45(1): 33 doi: 10.1016/j.ejca.2008.08.024
6
Maria Pia Santacroce, Anna Selene Pastore, Antonella Tinelli, Michele Colamonaco, Giuseppe Crescenzo. Implications for chronic toxicity of benzo[a]pyrene in sea bream cultured hepatocytes: Cytotoxicity, inflammation, and cancerogenesisEnvironmental Toxicology 2015; 30(9): 1045 doi: 10.1002/tox.21978
7
Ross C. Smith. Biliary Tract and Gallbladder CancerMedical Radiology 2014; : 67 doi: 10.1007/978-3-642-40558-7_5
8
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 549 doi: 10.1007/978-3-319-26956-6_29
9
Boris R.A. Blechacz, Gregory J. Gores. Molecular Genetics of Liver Neoplasia2010; : 75 doi: 10.1007/978-1-4419-6082-5_5
10
Junko Umeda, Takao Itoi, Atsushi Sofuni, Fumihide Itokawa, Toshio Kurihara, Takayoshi Tsuchiya, Kentaro Ishii, Shujiro Tsuji, Nobuhito Ikeuchi, Reina Tanaka, Ryosuke Tonozuka, Mitsuyoshi Honjo, Shuntaro Mukai, Toshitaka Nagao, Hisashi Oshiro, Fuminori Moriyasu. Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary CancersJournal of Oncology 2013; 2013: 1 doi: 10.1155/2013/170625
11
Piera Zaccari, Vincenzo Cardinale, Carola Severi, Federica Pedica, Guido Carpino, Eugenio Gaudio, Claudio Doglioni, Maria Chiara Petrone, Domenico Alvaro, Paolo Giorgio Arcidiacono, Gabriele Capurso. Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreasWorld Journal of Gastroenterology 2019; 25(31): 4343-4359 doi: 10.3748/wjg.v25.i31.4343
12
Xiaofang Liu, Yongliang Duan, Fanmin Kong, Zheng Xu, Xianting Zhou, Cuisheng Zhang, Shaojun Li. The study on DNA methylation of p53-Bax mitochondrial apoptosis pathway in cholangiocarcinomaThe Chinese-German Journal of Clinical Oncology 2009; 8(4): 214 doi: 10.1007/s10330-009-0015-9
13
R Sriraksa, C Zeller, M A El-Bahrawy, W Dai, J Daduang, P Jearanaikoon, S Chau-in, R Brown, T Limpaiboon. CpG-island methylation study of liver fluke-related cholangiocarcinomaBritish Journal of Cancer 2011; 104(8): 1313 doi: 10.1038/bjc.2011.102
14
Xiao-Fang Liu, Kun Tang, Lu-Lu Sui, Gang Xu. Cholangiocarcinoma: Present Status and Molecular Aspects of DiagnosisOncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2015; 22(4): 177 doi: 10.3727/096504015X14343704124386
15
L Yang, S Feng, Y Yang. Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysisCancer Gene Therapy 2016; 23(12): 439 doi: 10.1038/cgt.2016.64
16
Jinzhu Yang, Tiantian Wang, Gang Lin, Mingzhu Li, Ronghua Zhu, Alexandros Yiannikouris, Yanjiao Zhang, Kangsen Mai. The Assessment of Diet Contaminated with Aflatoxin B1 in Juvenile Turbot (Scophthalmus maximus) and the Evaluation of the Efficacy of Mitigation of a Yeast Cell Wall ExtractToxins 2020; 12(9): 597 doi: 10.3390/toxins12090597
17
Sukant Garg, Sajal Afzal, Ahmed Elwakeel, Damini Sharma, Navaneethan Radhakrishnan, Jaspreet Kaur Dhanjal, Durai Sundar, Sunil C. Kaul, Renu Wadhwa. Marine Carotenoid Fucoxanthin Possesses Anti-Metastasis Activity: Molecular EvidenceMarine Drugs 2019; 17(6): 338 doi: 10.3390/md17060338
18
Switching p53 states by calcium: dynamics and interaction of stress systemsMolecular BioSystems 2013; 9(3): 508 doi: 10.1039/c3mb25277a
19
Tolutope Oyasiji, Jianliang Zhang, Boris Kuvshinoff, Renuka Iyer, Steven N. Hochwald. Molecular Targets in Biliary Carcinogenesis and Implications for TherapyThe Oncologist 2015; 20(7): 742 doi: 10.1634/theoncologist.2014-0442
20
Juthamas Yosudjai, Sopit Wongkham, Siwanon Jirawatnotai, Worasak Kaewkong. Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma (Review)Biomedical Reports 2019;  doi: 10.3892/br.2019.1188
21
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_29-1
22
Samuel Romeo Obiekwe, Nathaly Suzett De La Roca, Jean Saric. Surgical Challenges in the Management of Liver Disease2019;  doi: 10.5772/intechopen.81326
23
Arzu DENLER KILIÇ, Muhammed Cem KOÇKAR, Mete AKIN, Pınar ASLAN KOŞAR, Nilüfer ŞAHİN CALAPOĞLU. The Role of P53 Gene Mutation Detected in Bile Fluid in the Diagnosis and Determining Prognosis of Patients with Extrahepatic CholangiocarcinomaAkdeniz Medical Journal 2022; : 326 doi: 10.53394/akd.1059486
24
Domenico Alvaro, Vincenzo Cardinale. Biliary Tract and Gallbladder CancerMedical Radiology 2014; : 99 doi: 10.1007/978-3-642-40558-7_7